Catalytic activity of human ADAM33 (Q28191609)

1

0 references

Feng Zhu

2

0 references

Jianjun Liu

3

0 references

Wenyan Wang

4

0 references

Rumin Zhang

5

0 references

Charles G Garlisi

6

0 references

Yan-Hui Liu

7

0 references

Shihong Wang

8

0 references

Himanshu Shah

9

0 references

Yuntao Wan

10

0 references

Shelby P Umland

Journal of Biological Chemistry

11

0 references

language of work or name

English

0 references

publication date

12 March 2004

0 references

published in

0 references

volume

279

0 references

issue

11

0 references

page(s)

9818-30

0 references

cites work

Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Remarkable roles of proteolysis on and beyond the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

The ADAMs family of metalloproteases: multidomain proteins with multiple functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Human ADAM 12 (meltrin alpha) is an active metalloprotease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Intracellular maturation of the mouse metalloprotease disintegrin MDC15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Roles of Meltrin beta /ADAM19 in the processing of neuregulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Autolytic processing at Glu586-Ser587 within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Catalytic properties of ADAM19

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Human ADAM33: protein maturation and localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Identification and characterization of novel mouse and human ADAM33s with potential metalloprotease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase-containing proteins (review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Calpain inhibitor I increases beta-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase. Evidence that substrate availability limits beta-amyloid peptide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

A continuous spectrophotometric assay for the hepatitis C virus serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

A continuous fluorimetric assay for tumor necrosis factor-alpha converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

17 The kinetics of reversible tight-binding inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Human ADAM33 messenger RNA expression profile and post-transcriptional regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Crystal structures of acutolysin A, a three-disulfide hemorrhagic zinc metalloproteinase from the snake venom of Agkistrodon acutus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Membrane protein secretases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Regulation of APP cleavage by alpha-, beta- and gamma-secretases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Activation of ADAM 12 protease by copper

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200

Regulation of Human ADAM 12 Protease by the Prodomain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309696200